| HOME | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
| ||||||||||||||||||||||||||||||||
a Medical Surgical Research Center, National Center for Scientific Research, Havana City, Cuba
b Center of Natural Products, National Center for Scientific Research, Havana City, Cuba
Rosa Más, Center of Natural Products, National Center for Scientific Research, P.O. Box 6880 or 6990, Cubanac\|[aacute]\|n, Havana City, Cuba E-mail: dalmer{at}ip.etecsa.cu.
Decision Editor: John E. Morley, MB, BCh
Background. The present study was undertaken to investigate the effects of policosanol in older patients with type II hypercholesterolemia and more than one concomitant atherosclerotic risk factor.
Methods. After 6 weeks on a lipid-lowering diet, 179 patients randomly received a placebo or policosanol at doses of 5 followed by 10 mg per day for successive 12-week periods of each dose. Policosanol (5 and 10 mg/d) significantly (p < .001) reduced low-density lipoprotein cholesterol (LDL-C; 16.9% and 24.4%, respectively) and total cholesterol (TC; 12.8% and 16.2%, respectively), while significantly (p < .01) increasing (p < .001) high-density lipoprotein cholesterol (HDL-C) by 14.6% and 29.1%, respectively.
Results. Policosanol significantly decreased (p < .01) the ratios of LDL-C to HDL-C (29.1%) and TC to HDL-C (28%) at study completion, although triglycerides remained unchanged. Policosanol, but not the placebo, significantly improved (p .01) cardiovascular capacity, which was assessed using the Specific Activity Scale. No serious adverse experiences occurred in policosanol patients (p < .01), compared with seven adverse experiences (7.9%) reported by placebo patients.
Conclusions. This study shows that policosanol is effective, safe, and well tolerated in older hypercholesterolemic patients.
This article has been cited by other articles:
 |
|
 |
|
  M. F Dulin, L. F Hatcher, H. C Sasser, and T. A Barringer Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1543 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N Kassis and P. J. Jones Lack of cholesterol-lowering efficacy of Cuban sugar cane policosanols in hypercholesterolemic persons. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1003 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Aronow Guest Editorial: Should Hypercholesterolemia in Older Persons Be Treated to Reduce Cardiovascular Events? J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2002; 57(7): M411 - 413. [Full Text]
|
|
|
|
|
|
J. E. Morley Editorial: Drugs, Aging, and the Future J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2002; 57(1): M2 - 6. [Full Text] [PDF]
|
|
| HOME | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
